Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This case study reports the first documentation of the intermittent nature of chronic telogen effluvium and suggests a link between emotional stress and hair shedding severity.

This review found no significant evidence supporting postpartum telogen effluvium as a distinct condition, suggesting its incidence is uncertain and possibly negligible.

This letter to the editor on postpartum telogen effluvium does not include new research findings or data.

A horse's sudden hair loss was caused by an allergic reaction to a coat conditioning powder.

This study suggests that telogen effluvium is more closely related to the severity of COVID-19 and associated inflammation than to hormonal factors, with women showing a higher prevalence.

This article discusses the causes and diagnosis of telogen effluvium, highlighting traction alopecia as a useful model for studying hair loss, but reports no new clinical results.

Hair transplant surgery can cause temporary hair loss in the area where hair was taken from.

Telogen effluvium causes sudden hair loss, often due to stress or changes, and is treated by addressing the cause and offering support.

This case series reported that telogen effluvium may reveal underlying traction alopecia, emphasizing the importance of recognizing this to ensure accurate diagnosis and treatment.

This study suggests that observing the acute telogen effluvium triad—frontal fringe, temporal recess, and occipital fringe—can aid in diagnosing telogen effluvium during resolution phases, despite challenges like negative pull tests.

In this case report, a patient experienced hair loss after a surgical procedure but did not encounter the same issue following a later surgery with similar anesthesia.

This clinical study found that Rosmarinum officinalis mother tincture significantly improved hair volume and density in individuals with diffuse hair loss by enhancing hair parameters measured through a hair shedding visual scale and ponytail thickness test.

In this study, both Unani formulations tested were effective in managing Telogen Effluvium, with Itrifal Kishneezi and Roghan Amla showing slightly faster early results in reducing hair shedding, although overall efficacy between the two treatments was comparable.

The food supplement may help reduce hair shedding and improve hair growth.

This simulation study found that higher cannabis exposure in a virtual population was associated with increased hair shedding severity and reduced follicular density, but these results are based on modeled data and cannot establish causal relationships.

This study found that a novel drinkable supplement significantly increased hair density and reduced hair shedding over six months in women with telogen effluvium, although the authors emphasize the need for larger, placebo-controlled trials to confirm these promising results.

This study found a significant association between glass ceiling syndrome and telogen effluvium in female health workers, suggesting that the stress from career barriers may contribute to hair loss, with education and occupational status also being related factors.

This study reported that 5% topical minoxidil lotion may be beneficial for enhancing hair regrowth in patients with telogen effluvium, although its effectiveness is limited by the self-healing nature of the condition and the small sample size.

In this study, Pilopeptan® Intensive, a nutritional supplement containing hydrolyzed collagen, Group B vitamins, and zinc, was found to significantly improve hair parameters in telogen effluvium patients, with sustained benefits observed posttreatment, although mild side effects were reported by some participants.

This retrospective study observed that telogen effluvium, a type of diffuse hair loss, frequently occurs in females aged 18–30 following SARS-CoV-2 infection, often accompanied by nutritional deficiencies, suggesting an association between COVID-19 and micronutrient deficiency, with acute cases being most common but chronic cases possible.

In this study, telogen effluvium is characterized as a common condition in women involving sudden hair shedding due to hair follicles prematurely entering the telogen phase, with potential triggers including fever, childbirth, and stress.

This study observed that LED therapy improved hair regrowth and reduced hair loss in patients with post-COVID telogen effluvium, with or without androgenetic alopecia, compared to those who did not receive LED treatment.

This study in Saudi Arabia found that 59.70% of participants experienced hair shedding during or after COVID-19, with significant risk factors including being female, having a history of telogen effluvium, and receiving COVID-19 antiviral treatment.

This study developed and validated the Hair-Shedding Visual Scale for Asian Women, finding it to be an effective tool for identifying FPHL and TE.

In this study, the researchers aimed to investigate the incidence of telogen effluvium, a type of temporary hair loss, among COVID-19 survivors working at Benha University Hospitals to understand the potential impact of the pandemic on the hair health of healthcare professionals.

This study analyzed serum vitamin D levels in patients with telogen effluvium to explore their potential relationship, but it reports no new clinical findings.

This study found that 72% of patients who recovered from COVID-19 during the second wave reported experiencing significant hair loss, characteristic of telogen effluvium.

This study suggests that capillarectasia, or dilation of scalp capillaries, may help distinguish COVID-19-associated telogen effluvium from classic acute telogen effluvium.

This review discusses the phases of the human hair cycle, the factors affecting telogen effluvium, and the need for investigation if persistent hair shedding occurs, but reports no new clinical results.

This article presents a case of telogen effluvium, a condition causing hair loss, occurring three months after a COVID-19 infection.